Vitamin D Supplementation Promotes Regulatory T-Cells to Maintain Immune Homeostasis After Surgery for Early Stages of Colorectal Cancer

Overview

Journal In Vivo

Specialty Oncology

Date 2023 Jan 2

PMID 36593062

Authors

Patnapa Srichomchey

Sophida Sukprasert

Nathapong Khulasittijinda

Narin Voravud

Chucheep Sahakitrungruang

Putthapoom Lumjiaktase

Affiliations

Soon will be listed here.

Abstract

Background/aim: Vitamin D (VD) affects the regulation of the immune system, including the differentiation and function of regulatory T-cells (Tregs). Tregs play an important role in maintaining immune homeostasis in patients with colorectal cancer (CRC). The effects of VD on Treg-associated immune function were investigated in Thai patients in the early stages of CRC.

Materials And Methods: Twenty-eight patients were randomized to one of two groups: Untreated or treatment with VD for 3 months. Whole blood samples were collected at baseline, and at 1 and 3 months. Peripheral blood mononuclear cells were isolated and the populations of forkhead box P3-positive Treg cells was analyzed by flow cytometry. The levels of Treg-associated cytokines, interleukin 10 (IL-10) and transforming growth factor beta 1 (TGF-β1), were measured by enzyme-linked immunosorbent assays.

Results: Serum VD levels of the VD-treated group were significantly increased at 1 (p=0.017) and 3 months (p<0.001) compared to the untreated control group. The mean percentage of Tregs was maintained between 1 and 3 months in the VD-treated group. At 3 months, the untreated group had significantly lower Treg levels than the VD-treated group (p=0.043). Serum IL-10 levels of the VD-treated group were statistically increased at 1 month compared to the control group (p=0.032). No significant difference in serum TGF-β1 levels was observed between the two groups. However, the TGF-β1 level in the VD-treated group at 1 month was lower than that of the control.

Conclusion: Our findings suggest that VD supplementation can maintain immune responses in the early stages of CRC, helping to control Treg function. Therefore, VD should be supplemented to maintain immune homeostasis, especially in patients with vitamin D deficiency.

Citing Articles

Exploring Anti-Inflammatory Treatment as Upstream Therapy in the Management of Atrial Fibrillation.

Zheng E, Warchol I, Mejza M, Mozdzan M, Strzeminska M, Bajer A J Clin Med. 2025; 14(3).

PMID: 39941553 PMC: 11818443. DOI: 10.3390/jcm14030882.

Comparison of Vitamin D3 Supplementation Doses of 1,000, 2,000, 4,000 and 8,000 IU in Young Healthy Individuals.

Kralova M, Jirasko M, Dedeckova E, Hatakova H, Broz P, Simanek V In Vivo. 2024; 39(1):452-458.

PMID: 39740917 PMC: 11705152. DOI: 10.21873/invivo.13848.

Effect of vitamin D adjuvant therapy on the proportion of regulatory T cells in peripheral blood and pregnancy outcome of patients with recurrent miscarriage.

Ling S J Obstet Gynaecol Res. 2024; 51(1):e16151.

PMID: 39543837 PMC: 11635183. DOI: 10.1111/jog.16151.

Vitamin D and hypertension: Is there any significant relation?.

Vakkalagadda N, Narayana S, Sree G, Bethineedi L, Kutikuppala L, Medarametla G Chronic Dis Transl Med. 2024; 10(2):156-158.

PMID: 38872764 PMC: 11166674. DOI: 10.1002/cdt3.83.

Circulating vitamin D level before initiating chemotherapy impacts on the time-to-outcome in metastatic colorectal cancer patients: systematic review and meta-analysis.

Ottaiano A, Iacovino M, Santorsola M, Facchini S, Iervolino D, Perri F J Transl Med. 2024; 22(1):119.

PMID: 38291479 PMC: 10826188. DOI: 10.1186/s12967-024-04889-2.

References

Gorham E, Garland C, Garland F, Grant W, Mohr S, Lipkin M . Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med. 2007; 32(3):210-6. DOI: 10.1016/j.amepre.2006.11.004. View

Massague J, Seoane J, Wotton D . Smad transcription factors. Genes Dev. 2005; 19(23):2783-810. DOI: 10.1101/gad.1350705. View

Ashtari F, Toghianifar N, Zarkesh-Esfahani S, Mansourian M . Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. Neuroimmunomodulation. 2015; 22(6):400-4. DOI: 10.1159/000439278. View

Frey D, Droeser R, Viehl C, Zlobec I, Lugli A, Zingg U . High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer. 2009; 126(11):2635-43. DOI: 10.1002/ijc.24989. View

Alvaro T, Lejeune M, Salvado M, Bosch R, Garcia J, Jaen J . Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res. 2005; 11(4):1467-73. DOI: 10.1158/1078-0432.CCR-04-1869. View

Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards D . Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest. 2005; 116(1):146-55. PMC: 1307558. DOI: 10.1172/JCI21759. View

Dennis K, Blatner N, Gounari F, Khazaie K . Current status of interleukin-10 and regulatory T-cells in cancer. Curr Opin Oncol. 2013; 25(6):637-45. PMC: 4322764. DOI: 10.1097/CCO.0000000000000006. View

Joshi S, Pantalena L, Liu X, Gaffen S, Liu H, Rohowsky-Kochan C . 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol. 2011; 31(17):3653-69. PMC: 3165548. DOI: 10.1128/MCB.05020-11. View

Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D . Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol. 2008; 27(2):186-92. DOI: 10.1200/JCO.2008.18.7229. View

10.

Sinicrope F, Rego R, Ansell S, Knutson K, Foster N, Sargent D . Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology. 2009; 137(4):1270-9. PMC: 2873775. DOI: 10.1053/j.gastro.2009.06.053. View

11.

Virani S, Bilheem S, Chansaard W, Chitapanarux I, Daoprasert K, Khuanchana S . National and Subnational Population-Based Incidence of Cancer in Thailand: Assessing Cancers with the Highest Burdens. Cancers (Basel). 2017; 9(8). PMC: 5575611. DOI: 10.3390/cancers9080108. View

12.

Bilani N, Elson L, Szuchan C, Elimimian E, Saleh M, Nahleh Z . Newly-identified Pathways Relating Vitamin D to Carcinogenesis: A Review. In Vivo. 2021; 35(3):1345-1354. PMC: 8193311. DOI: 10.21873/invivo.12387. View

13.

Giovannucci E, Liu Y, Rimm E, Hollis B, Fuchs C, Stampfer M . Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006; 98(7):451-9. DOI: 10.1093/jnci/djj101. View

14.

Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C . Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010; 10(4):482-96. DOI: 10.1016/j.coph.2010.04.001. View

15.

Prietl B, Treiber G, Mader J, Hoeller E, Wolf M, Pilz S . High-dose cholecalciferol supplementation significantly increases peripheral CD4⁺ Tregs in healthy adults without negatively affecting the frequency of other immune cells. Eur J Nutr. 2013; 53(3):751-9. DOI: 10.1007/s00394-013-0579-6. View

16.

Jeffery L, Burke F, Mura M, Zheng Y, Qureshi O, Hewison M . 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009; 183(9):5458-67. PMC: 2810518. DOI: 10.4049/jimmunol.0803217. View

17.

Sarkar S, Hewison M, Studzinski G, Li Y, Kalia V . Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer. Crit Rev Clin Lab Sci. 2015; 53(2):132-45. DOI: 10.3109/10408363.2015.1094443. View

18.

Kim J, Baek D, Baek J, Kang B, Song S, Kim H . Clinical Impact of Postoperative Vitamin D Deficiency on the Recurrence of Colon Cancer After Curative Surgical Resection. Anticancer Res. 2021; 41(7):3683-3688. DOI: 10.21873/anticanres.15159. View

19.

Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay N . Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res. 2006; 12(2):465-72. DOI: 10.1158/1078-0432.CCR-05-1886. View

20.

von Essen M, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C . Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 2010; 11(4):344-9. DOI: 10.1038/ni.1851. View